Results 171 to 180 of about 178,855,135 (215)

Bisphosphonate-associated osteonecrosis of the jaw

Menopause International, 2007
The term 'osteonecrosis of the jaw' is typically used to describe the exposure of bone within the oral cavity. These lesions are often painful and can result in pathological fracture and disfigurement in severe cases. Infection and dental extractions commonly precede presentation, although lesions can occur spontaneously.
Neil, Basu, David M, Reid
openaire   +2 more sources

Bisphosphonate-Associated Osteonecrosis of the Jaw

New England Journal of Medicine, 2006
A 54-year-old man with a 3-year history of IgG myeloma, complicated by hypercalcemia, who was being treated with dexamethasone, lenalidomide, filgrastim, darbepoetin alfa, and pamidronate, presented with a 1-month history of severe bilateral jaw pain.
Nathaniel Treister, Sook-Bin Woo
openaire   +3 more sources

Intravenous Bisphosphonate–Associated Osteonecrosis of the Jaw

Journal of Periodontology, 2007
Background: Bisphosphonates have received attention in the dental and medical scientific literature because of spontaneous necrosis of the jaw subsequent to their use. As the population ages, the use of these medications is increasing; the medical benefits seem to outweigh the risk for osteonecrosis of the jaw (ONJ).Methods: A 71‐year‐old white male ...
Thomas A, Statz, Janet M, Guthmiller, Lewis A, Humbert, Georgia K, Johnson   +3 more
openaire   +2 more sources

Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2007
To describe our experience in prevention and treatment of mandibular and maxillary osteonecrosis, an emerging complication of long-term intravenous administration of bisphosphonates.Between February 2004 and February 2006, 10 patients who had received zoledronic acid intravenously because of multiple bone myelomas or bone metastases were treated for ...
D. Rossi, O. D'Orto, D. Pagani, A. Agazzi, U. Marzano, G. Derada Troletti, W. Fontanella, L. Pignataro   +7 more
openaire   +2 more sources

Bisphosphonate-associated osteonecrosis of the jaws

Climacteric, 2007
Bisphosphonate-associated osteonecrosis of the jaws (ONJ) was first reported in the maxillofacial surgery literature in North America[[1-3]] and Australia in 2003[[4]].
openaire   +3 more sources

Recent Recommendations on Bisphosphonate-Associated Osteonecrosis of the Jaw

Dental Update, 2008
There is increasing awareness of the importance of osteonecrosis of the jaw developing in patients taking bisphosphonates. A recent working party of the American Society for Bone and Mineral Research has developed recommendations on the prevention and treatment of this condition which dentists will find useful.
Yazdana, Arrain, Tahir, Masud
openaire   +2 more sources

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

Supportive Care in Cancer, 2006
Prevalence of bisphosphonate-associated osteonecrosis of the jaws within the catchment area of a university hospital maxillofacial unit and to review the outcome of treatment.In a retrospective study, all patients with osteonecrosis, osteomyelitis and osteoradionecrosis treated in the period from January 2000 to March 2005 in the department for Maxillo
Christian, Walter, Knut A, Grötz, Martin, Kunkel, Bilal, Al-Nawas   +3 more
openaire   +2 more sources

Bisphosphonate-associated osteonecrosis (BON) of the jaws: A possible treatment?

Journal of Oral and Maxillofacial Surgery, 2006
Management of bisphosphonate-associated osteonecrosis (BON) of the jaws is currently a very topical subject. At present, there is no effective treatment for this condition. Several authors have recommended that prevention, when possible, of BON in patients at risk is the gold standard.
VESCOVI, Paolo, MERIGO E, MELETI, Marco, MANFREDI, Maddalena   +3 more
openaire   +3 more sources

Incidence and risk factors of bisphosphonate‐associated osteonecrosis of the jaws

Head & Neck, 2007
AbstractBackgroundIntravenous bisphosphonate therapy has been used for treatment of benign and malignant bone diseases and has been linked to osteonecrosis of the jaws.MethodsRecords of 638 patients treated with intravenous bisphosphonates were reviewed.
Matthew R, Stumpe, Rakesh K, Chandra, Furhan, Yunus, Sandeep, Samant   +3 more
openaire   +2 more sources

Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws

Dentomaxillofacial Radiology, 2006
It is important to recognize osteonecrosis of the jaws in patients treated with bisphosphonates because an early diagnosis can make a significant difference to the outcome of the disease. The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis (BON) in order to aid its prompt recognition.A conventional radiograph,
CHIANDUSSI, SILVIA, BIASOTTO, MATTEO, DORE, FRANCA, CAVALLI, FABIO, COVA, MARIA ASSUNTA, DI LENARDA, Roberto   +5 more
openaire   +3 more sources